Detalhe da pesquisa
1.
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies.
Curr Opin Oncol
; 36(4): 326-331, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726843
2.
Patient metabolic profile defined by liver and muscle 18F-FDG PET avidity is independently associated with overall survival in gastric cancer.
Gastric Cancer
; 27(3): 548-557, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436762
3.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol
; 24(7): 744-756, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329891
4.
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Lancet Oncol
; 24(10): 1073-1082, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666264
5.
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy.
Int J Cancer
; 152(10): 2109-2122, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573352
6.
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.
Ann Surg
; 277(3): e538-e544, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387205
7.
Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.
Ann Surg
; 277(5): 798-805, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766391
8.
Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry: A Novel Path for Precision Oncology.
Ann Surg
; 278(4): 506-518, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436885
9.
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
Ann Surg
; 278(3): e511-e518, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762546
10.
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Cancer
; 128(15): 2958-2966, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35647938
11.
Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?
Ann Surg
; 276(6): 1017-1022, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214465
12.
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant Treatment.
Curr Treat Options Oncol
; 23(7): 1044-1058, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524838
13.
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma.
Future Oncol
; 18(29): 3255-3266, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000541
14.
PD-L1 expression and overall survival in Asian and western patients with gastric cancer.
Future Oncol
; 18(21): 2623-2634, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616013
15.
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
Cancer
; 127(23): 4393-4402, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351646
16.
Comparison of Long- and Short-term Outcomes in 845 Open and Minimally Invasive Gastrectomies for Gastric Cancer in the United States.
Ann Surg Oncol
; 28(7): 3532-3544, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709174
17.
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.
Ann Surg Oncol
; 28(9): 4829-4838, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33566242
18.
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.
Ann Surg Oncol
; 28(12): 7040-7050, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830355
19.
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 21(6): 821-831, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437664
20.
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.
Oncologist
; 25(1): e68-e74, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570517